Table 3 Univariate analysis of patients with CAA-ICH classified by the presence of postoperative rebleeding
Rebleeding( +) (n = 12) | Rebleeding(-) (n = 38) | P value | |
|---|---|---|---|
Character | |||
Age, median (range), year | 78.5 (71–86) | 78 (57–89) | 0.356 |
Female, No. (%) | 10 (83) | 24 (63) | 0.172 |
Hypertension, No. (%) | 6(50) | 15 (39) | 0.738 |
Diabetes, No. (%) | 2 (17) | 0 | 0.054 |
Dementia, No. (%) | 4 (33) | 11 (29) | 0.518 |
Antithrombotic therapy, No. (%) | 7 (58) | 9 (24) | 0.032 |
Anticoagulant therapy, No. (%) | 3 (25) | 2 (5) | 0.082 |
Antiplatelet therapy, No. (%) | 4 (33) | 7 (18) | 0.240 |
Systemic factor | |||
Hematoma vol. (before)*1, Mean (SD), mL | 85 (36) | 81 (32) | 0.721 |
Hematoma vol. (after)*2, Mean (SD), mL | 7 (6) | 6 (6) | 0.687 |
Hematoma vol. (rebleed)*3, Mean (SD), mL | 28 (14) | 6 (6) | < 0.001 |
Systolic blood pressure, Mean (SD), mmHg | 184 (25) | 173 (34) | 0.281 |
Diastolic blood pressure, Mean (SD), mmHg | 88 (30) | 84 (22) | 0.605 |
Preoperative PT-INR, Mean (SD) | 1.3(0.64) | 1.0(0.12) | 0.099 |
Preoperative APTT, Mean (SD) | 29(8) | 28(4) | 0.521 |
Surgeon’s experience, Mean (SD), year | 4.6(1.8) | 5.2(2.9) | 0.528 |
Surgical time, Mean (SD), minute | 196 (60) | 188 (68) | 0.731 |
Intraoperative bleeding volume, Mean (SD), ml | 508 (435) | 216 (160) | 0.042 |
Outcome | |||
Hospital stays, Mean (SD), day | 25(20) | 31(18) | 0.391 |
mRS 0–3 at the discharge, No. (%) | 0 | 11 (28) | 0.032 |
mRS 6 at the discharge, No. (%) | 5 (42) | 3 (8) | 0.014 |